News

26 07, 2016

“Print-Age” An integrated approach for the promotion of health of old and fragile people: infections prevention, nutritional integration and personalized therapy

Diatech Pharmacogenetics2017-08-21T10:43:11+02:00

19 05, 2016

Diatech and Inno-Train Diagnostik partecipate at the DGPhato congress

Diatech Pharmacogenetics2017-08-21T11:18:37+02:00

26 04, 2016

Diatech will be at States General Of Health Research

Diatech Pharmacogenetics2017-08-21T12:25:36+02:00

23 04, 2016

Diatech will be at the Workshop and School on Cancer Development and Complexity

Diatech Pharmacogenetics2017-08-21T12:35:32+02:00

27 10, 2015

Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma Treatment

Diatech Pharmacogenetics2022-04-08T11:29:11+02:00

27 03, 2015

Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020
Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020

News

Diatech Pharmacogenetics obtained by the European Union a founding of Euro 2 million in Horizon 2020

Diatech Pharmacogenetics2017-09-08T17:16:57+02:00

4 03, 2015

Il Gruppo Diatech partecipa a NGS 2015

Diatech Pharmacogenetics2022-04-19T16:39:04+02:00

28 05, 2014

Diatech Pharmacogenetics at the European at Human Genetics Conference, May 31st – June 3rd, 2014

Diatech Pharmacogenetics2017-08-22T10:26:15+02:00

6 10, 2013

Diatech partecipates at the “Fifth International Symposium: Primary systemic treatment in the management of operable breast cancer”
Diatech partecipates at the “Fifth International Symposium: Primary systemic treatment in the management of operable breast cancer”

News

Diatech partecipates at the “Fifth International Symposium: Primary systemic treatment in the management of operable breast cancer”

Diatech Pharmacogenetics2017-08-23T12:32:34+02:00

29 08, 2013

Diatech Pharmacogenetics updates its kit for the analysis of KRAS and NRAS on the basis of the Amgen-AIFA information note

Diatech Pharmacogenetics2017-08-23T12:55:50+02:00

Previous 678 Next